Management of adult patients with Langerhans cell histiocytosis: Recommendations from an expert panel on behalf of Euro-Histio-Net

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Girschikofsky, Michael ^a   Arico, Maurizio ^b   Castillo, Diego ^c   Chu, Anthony ^d   Doberauer, Claus ^e   Fichter, Joachim ^f   Haroche, Julien ^g   Kaltsas, Gregory A ^h   Makras, Polyzois ⁱ   Marzano, Angelo V ^j   De Menthon, Mathilde ^k   Micke, Oliver ^l   Passoni, Emanuela ^j   Seegenschmiedt, Heinrich M ^m   Tazi, Abdellatif ^k   McClain, Kenneth L ⁿ  

^a ELISABETHINEN HOSPITAL   (Austria)

^b UNIVERSITY OF FLORENCE   (Italy)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e Department of Psychiatry Psychotherapy and Psychosomatics   (Germany)

^f Paracelsus Klinik   (Germany)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ IASO GENERAL HOSPITAL   (Greece)

^j FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^k SAINT LOUIS HOSPITAL   (France)

^l FRANZISKUS HOSPITAL   (Germany)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ TEXAS CHILDREN S CANCER CENTER   (United States)

more..

Author keywords

Adult; Histiocytosis; Langerhans

Indexed keywords

AZATHIOPRINE; CHLORMETHINE; CLOFARABINE; CYTARABINE; ETOPOSIDE; IMATINIB; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; PSORALEN; RETINOIC ACID; THALIDOMIDE; THYROTROPIN; VINCRISTINE;

BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD CLOTTING; BONE; BONE MARROW; CENTRAL NERVOUS SYSTEM; COLORECTAL POLYP; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FREE THYROXINE INDEX; HUMAN; LANGERHANS CELL HISTIOCYTOSIS; LIVER; MOUTH MUCOSA; NERVE DEGENERATION; PLEURODESIS; PNEUMOTHORAX; PREGNANCY; PROGNOSIS; REVIEW; SKIN; SKIN SURGERY; SPLEEN; SURGICAL DRAINAGE; THORAX RADIOGRAPHY; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URINALYSIS;

ADULT; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 84877627976     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-72     Document Type: Review

References (74)

1. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Arico M, Eur J Cancer 2003 39 16 2341 2348 (Pubitemid 37214858)
2. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. Willman CL, N Engl J Med 1994 331 3 154 160 (Pubitemid 24209565)
3. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Yousem SA, Am J Surg Pathol 2001 25 5 630 636 (Pubitemid 32423361)
4. Recurrent BRAF mutations in Langerhans cell histiocytosis. Badalian-Very G, Blood 2010 116 11 1919 1923
5. Pathogenesis of Langerhans Cell Histiocytosis. Badalian-Very G, Annu Rev Pathol 2013 24 8 1 20
6. Association of Langerhans cell histiocytosis with malignant neoplasms. Egeler RM, Cancer 1993 71 3 865 873 (Pubitemid 23051395)
7. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. Lee JS, J Korean Med Sci 2006 21 3 577 580
8. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Lau SK, Chu PG, Weiss LM, Am J Surg Pathol 2008 32 4 615 619 (Pubitemid 351458304)
9. Swerdlow SHC, International Agency for Research on, Cancer and O. World Health: WHO classification of tumours of haematopoietic and lymphoid tissues International Agency for Research on Cancer (IARC) 2008
10. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Valladeau J, Immunity 2000 12 1 71 81 (Pubitemid 30069216)
11. Minkov M, Grois N, McClain K, Nanduri V, Rodriguez-Galindo C, Simonitsch-Klupp I, Visser J, Weitzmann S, Whitlock J, Windebank K, Langerhans Cell Histiocytosis-Histiocyte Society Evaluation and Treatment Guidelines 2009 cited; Available from: http://www.histiocytesociety.org/document.doc?id=290
12. Familial clustering of Langerhans cell histiocytosis. Arico M, Br J Haematol 1999 107 4 883 888 (Pubitemid 30020164)
13. McClain K, Bone and Soft Tissue Involvement-Oral Presentation at the Annual Meeting of the Histiocyte Society, Vienna 2011
14. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Phillips M, Pediatr Blood Cancer 2009 52 1 97 101
15. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma]. Szturz P, Vnitr Lek 2010 56 11 1177 1193
16. Rapidly fatal Langerhans' cell histiocytosis in an adult. Teng CL, J Formos Med Assoc 2005 104 12 955 959
17. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Grois N, Pediatr Blood Cancer 2006 46 2 228 233
18. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. Kaltsas GA, J Clin Endocrinol Metab 2000 85 4 1370 1376 (Pubitemid 32289475)
19. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Prosch H, Pediatr Blood Cancer 2004 43 5 594 599 (Pubitemid 39313960)
20. Endocrine manifestations in Langerhans cell histiocytosis. Makras P, Trends Endocrinol Metab 2007 18 6 252 257 (Pubitemid 47068968)
21. Endocrine disorders in pediatric-onset Langerhans Cell Histiocytosis. Amato MC, Horm Metab Res 2006 38 11 746 751 (Pubitemid 44885428)
22. Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Makras P, Neuroradiology 2006 48 1 37 44 (Pubitemid 43336691)
23. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. Donadieu J, J Clin Endocrinol Metab 2004 89 2 604 609 (Pubitemid 38269865)
24. Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities. Alexandraki KI, QJM 2008 101 1 31 40
25. Reduced bone mineral density in adult patients with Langerhans cell histiocytosis. Makras P, Pediatr Blood Cancer 2012 58 5 819 822
26. Caputo R, A Text Atlas of Histiocytic Syndromes Informa HealthCare 1998
27. Gastrointestinal tract langerhans cell histiocytosis: A clinicopathologic study of 12 patients. Singhi AD, Montgomery EA, Am J Surg Pathol 2011 35 2 305 310
28. Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone). Yasko AW, J Bone Joint Surg Am 1998 80 2 219 228 (Pubitemid 28103386)
29. Isolated adult Langerhans' cell histiocytosis in cervical lymph nodes: should it be treated? Lo WC, J Laryngol Otol 2009 123 9 1055 1057
30. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis. Hoeger PH, Arch Dis Child 2000 82 6 483 487 (Pubitemid 30367059)
31. Satisfactory remission achieved by PUVA therapy in Langerhans cell hisiocytosis in an elderly patient. Sakai H, J Dermatol 1996 23 1 42 46 (Pubitemid 26061509)
32. Cutaneous Langerhans cell histiocytosis in an elderly man successfully treated with narrowband ultraviolet B. Imafuku S, Br J Dermatol 2007 157 6 1277 1279 (Pubitemid 350115683)
33. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide. Sander CS, Kaatz M, Elsner P, Dermatology 2004 208 2 149 152 (Pubitemid 38446016)
34. A phase II trial using thalidomide for Langerhans cell histiocytosis. McClain KL, Kozinetz CA, Pediatr Blood Cancer 2007 48 1 44 49 (Pubitemid 44871592)
35. Chu A, Dermatological Aspects and Presentation of an Adult Clinic-Oral Presentation at the Annual Meeting of the Histiocyte Society, Vienna 2011
36. Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate. Steen AE, Br J Dermatol 2001 145 1 137 140 (Pubitemid 32862802)
37. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. Cantu MA, PLoS One 2012 7 8 43257
38. MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Derenzini E, Ann Oncol 2010 21 6 1173 1178
39. Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis. Montella L, J Bone Miner Metab 2009 27 1 110 113
40. Anti-inflammatory and angiostatic therapy in chemorefractory multisystem Langerhans' cell histiocytosis of adults. Reichle A, Br J Haematol 2005 128 5 730 732 (Pubitemid 40343244)
41. Drug therapy for the treatment of Langerhans cell histiocytosis. McClain KL, Expert Opin Pharmacother 2005 6 14 2435 2441 (Pubitemid 41701046)
42. Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. Montella L, Insabato L, Palmieri G, N Engl J Med 2004 351 10 1034 1035 (Pubitemid 39166273)
43. Response of histiocytoses to imatinib mesylate: fire to ashes. Janku F, J Clin Oncol 2010 28 31 633 e636
44. Reduced-intensity conditioned allogeneic haematopoietic transplantation in an adult with Langerhans' cell histiocytosis and thrombocytopenia with absent radii. Ingram W, Bone Marrow Transplant 2006 37 7 713 715
45. [Sustained remission in an adult patient with Langerhans cell histiocytosis following T-cell depleted allogenic cell transplantation]. Xicoy B, Med Clin (Barc) 2006 127 18 716 (Pubitemid 46051005)
46. Clofarabine in refractory Langerhans cell histiocytosis. Rodriguez-Galindo C, Pediatr Blood Cancer 2008 51 5 703 706
47. Cladribine activity in adult langerhans-cell histiocytosis. Saven A, Burian C, Blood 1999 93 12 4125 4130 (Pubitemid 29279254)
48. Adult langerhans cell histiocytosis of bones: a rare cancer network study. Atalar B, Acta Orthop Belg 2010 76 5 663 668
49. [Multifocal Langerhans cell histiocytosis of bone: indications for radiotherapy]. Gaundong Mbethe GL, Cancer Radiother 2010 14 8 759 762
50. Langerhans Cell Histiocytosis. Brady LW, Langerhans Cell Histiocytosis. Springer Verlag, Olschewski T, Seegenschmiedt MH, Micke O, 2008 397 423
51. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Greenberger JS, Int J Radiat Oncol Biol Phys 1979 5 10 1749 1755 (Pubitemid 10187521)
52. Radiotherapy in Langerhans-cell histiocytosis. 2 case reports and review of the literature. Heyd R, Rontgenpraxis 2000 53 2 51 61 (Pubitemid 30636763)
53. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Micke O, Seegenschmiedt MH, Int J Radiat Oncol Biol Phys 2002 52 2 496 513 (Pubitemid 34170855)
54. Current role of radiation therapy in the management of histiocytosis-X. Cassady JR, Hematol Oncol Clin North Am 1987 1 1 123 129 (Pubitemid 18071797)
55. Neuropathology of CNS disease in Langerhans cell histiocytosis. Grois N, Brain 2005 128 Pt 4 829 838 (Pubitemid 40516920)
56. Central nervous system disease in Langerhans cell histiocytosis. Grois N, J Pediatr 2010 156 6 873 881 881 e1
57. Retinoic acid therapy in «degenerative-like» neuro-langerhans cell histiocytosis: a prospective pilot study. Idbaih A, Pediatr Blood Cancer 2004 43 1 55 58 (Pubitemid 38744560)
58. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy. Imashuku S, Pediatr Blood Cancer 2008 50 2 308 311
59. Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. Chohan G, J Neurol Neurosurg Psychiatry 2012 83 5 573 575
60. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Allen CE, Pediatr Blood Cancer 2010 54 3 416 423
61. Personal communication about. Allen CE, Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside 2010
62. Adult pulmonary Langerhans' cell histiocytosis. Tazi A, Eur Respir J 2006 27 6 1272 1285 (Pubitemid 44914314)
63. Clinico-epidemiological features of pulmonary histiocytosis X. Watanabe R, Intern Med 2001 40 10 998 1003 (Pubitemid 33041139)
64. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. Vassallo R, N Engl J Med 2002 346 7 484 490 (Pubitemid 34441739)
65. Serial CT and lung function testing in pulmonary Langerhans cell histiocytosis. Tazi A, Marc K, Dominique S, de Bazelaire C, Crestani B, Chinet T, Israel-Biet D, Cadranel J, Frija J, Lorillon G, Valeyre D, Chevret S, Eur Respir J 2012 40 4 905 912
66. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Auerswald U, Barth J, Magnussen H, Lung 1991 169 6 305 309
67. Pulmonary Langerhans Cell Histiocytosis associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Lepavec J, Lorillon G, Jaïs X, Tcherakian C, Feuillet S, Dorfmüller P, Simonneau G, Humbert M, Tazi A, Chest 2012
68. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Lazor R, Thorax 2009 64 3 274 5
69. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Lorillon G, Am J Respir Crit Care Med 2012 186 9 930 2
70. Pneumothorax in pulmonary Langerhans cell histiocytosis. Mendez JL, Chest 2004 125 3 1028 32 (Pubitemid 38367296)
71. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Dauriat G, Transplantation 2006 81 5 746 50
72. Diabetes insipidus in pregnancy: etiology, evaluation, and management. Ananthakrishnan S, Endocr Pract 2009 15 4 377 82
73. Histiocytosis X and pregnancy. DiMaggio LA, Lippes HA, Lee RV, Obstet Gynecol 1995 85 5 Pt 2 806 9
74. Effect of pregnancy on lung function in adult pulmonary Langerhans cell histiocytosis. Sharma R, Maplethorpe R, Wilson G, J Matern Fetal Neonatal Med 2006 19 1 67 8